Rapid HIV Treatment Initiation, Access and Engagement in Care

NCT03512964 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Dolutegravir 50 MG
DRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet [DESCOVY]

Sponsor

Johns Hopkins University

Collaborators

[object Object]